Abstract
Objective: There is some controversy regarding the early onset or high incidence of coronary atherosclerosis in patients with systemic sclerosis (SSc). Measurements of the coronary calcification score (CCS) by multi-detector computed tomography (MDCT) is an accurate and non-invasive method for detecting coronary atherosclerosis, and a high level of CCS (≥160) can predict coronary events. This study examined the CCS using MDCT and evaluated the risk of coronary events in patients with SSc.
Introduction
Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by skin thickening and vascular abnormalities, most notably microvascular dysfunction like Raynaud’s phenomenon. In other chronic inflammatory diseases, such as Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE), persistent inflammation is known to accelerate macrovascular atherosclerosis. However, the impact of SSc on the large coronary arteries remains a subject of debate. This study aimed to determine if SSc patients are at an elevated risk for coronary artery disease by utilizing the Coronary Calcification Score (CCS), a proven metric for predicting future cardiovascular events.
Methods and Study Population
The researchers conducted a clinical study of 35 patients diagnosed with SSc at Pusan National University Hospital. The cohort consisted of 33 females and 2 males, with a mean age of 52 years and an average disease duration of 8 years. Patients were categorized into "limited" (n=20) and "diffuse" (n=15) subtypes.
Imaging was performed using a 16-slice Multi-Detector Computed Tomography (MDCT) scanner. Calcium deposits were quantified using the Agatston method. Additionally, the Framingham Risk Score (FRS) was calculated for 29 patients to estimate 10-year cardiovascular risk based on traditional factors such as age, cholesterol, and blood pressure.
Results
The study revealed a surprisingly low prevalence of coronary atherosclerosis in this population. The mean CCS for the total group was 10.1 ± 30.8. Crucially, 80% of the patients (28 out of 35) had a CCS of zero, and no patient reached the high-risk threshold of 160.
Risk stratification using the FRS further supported these findings, with 28 out of 29 evaluable patients categorized as "low risk" (<10% 10-year risk). Statistical analysis showed no significant difference in calcium scores between the limited and diffuse subtypes (p=0.462), nor did CCS correlate with disease duration or skin thickness scores.
Discussion
These results highlight an "inflammation paradox" in SSc. While the disease involves significant systemic inflammation and microvascular damage, the macrovascular coronary arteries appear relatively spared compared to other autoimmune conditions. This suggests that the fibrotic processes and microvascular damage characteristic of SSc may be driven by biological pathways distinct from those leading to traditional atherosclerotic plaque formation.
Conclusion
In this cohort, SSc patients demonstrated low coronary calcification scores and low predicted cardiovascular risk. While these findings are encouraging, the study's small sample size and predominantly female demographic suggest that larger, longitudinal multi-center studies are necessary to fully understand the long-term macrovascular risks associated with systemic sclerosis.
Summary updated